Clinical Trial Update: A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase II study evaluating the combination of gemcitabine with TS-1 for advanced or recurrent pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• TS-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Korea University Anam Hospital | Conditions: Pancreatic Neoplasm, Neoplasm Metastasis | Phase 2 | Status: COMPLETED